Malignant neoplasm of spinal cord
ICD-10 C72.0 is a billable code used to indicate a diagnosis of malignant neoplasm of spinal cord.
Malignant neoplasm of the spinal cord refers to cancerous tumors that originate in the spinal cord tissue. These tumors can be primary, arising directly from the spinal cord, or secondary, resulting from metastasis from other sites. Symptoms may include pain, weakness, sensory changes, and loss of bowel or bladder control, depending on the tumor's location and size. Imaging studies such as MRI and CT scans are crucial for diagnosis, allowing visualization of the tumor's size, location, and effect on surrounding structures. Molecular markers, including genetic mutations and protein expressions, can aid in determining the tumor type and guiding treatment options. Neurological function may be significantly impacted, necessitating a multidisciplinary approach for management, including neurosurgery, radiation therapy, and chemotherapy. Accurate coding is essential for appropriate treatment planning and reimbursement.
Comprehensive pathology reports, imaging studies, and treatment plans.
Diagnosis and treatment planning for spinal cord tumors, management of treatment side effects.
Ensure accurate staging and grading of tumors for appropriate coding.
Neurological assessments, imaging results, and functional status evaluations.
Evaluation of neurological deficits, management of pain and other symptoms.
Document neurological function changes and their correlation with imaging findings.
Used during surgical intervention for spinal cord tumors.
Surgical notes detailing the procedure and findings.
Ensure alignment with oncology treatment plans.
MRI and CT scans are essential for visualizing the tumor and assessing its impact on surrounding structures. Documentation of these studies is crucial for accurate coding.
